Mar 27 |
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 27 |
Earnings Scheduled For March 27, 2024
|
Mar 26 |
Altimmune Q4 2023 Earnings Preview
|
Mar 20 |
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
|
Mar 19 |
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
|
Feb 27 |
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Feb 27 |
Altimmune: Taking On Toughest Of Rivals In Obesity - I'm Unconvinced By Recent Rally
|
Feb 26 |
Altimmune Stock Surges, Kerrisdale Remains Short: What You Need To Know
|
Feb 14 |
(ALT) - Analyzing Altimmune's Short Interest
|
Feb 14 |
Altimmune stock climbs 9% amid Jefferies note on recent sell-off
|